Trial Outcomes & Findings for The Realtime Detection for Individual Variation of Analgesic :A Comparison of Sufentanil vs Fentanyl (NCT NCT01748071)

NCT ID: NCT01748071

Last Updated: 2013-11-25

Results Overview

According to the measurement of pressure pain threshold after intravenous injection of opioid analgesics

Recruitment status

COMPLETED

Target enrollment

120 participants

Primary outcome timeframe

10 minutes after the procedure

Results posted on

2013-11-25

Participant Flow

Participant milestones

Participant milestones
Measure
Sufentanil Group
Grouped by intravenous injection of sufentanil at the time of anesthesia induction
Fentanyl Group
Grouped by intravenous injection of fentanyl at the time of anesthesia induction
Saline Group
Grouped by intravenous injection of saline before the time of anesthesia induction
Overall Study
STARTED
40
40
40
Overall Study
COMPLETED
38
38
40
Overall Study
NOT COMPLETED
2
2
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Sufentanil Group
Grouped by intravenous injection of sufentanil at the time of anesthesia induction
Fentanyl Group
Grouped by intravenous injection of fentanyl at the time of anesthesia induction
Saline Group
Grouped by intravenous injection of saline before the time of anesthesia induction
Overall Study
Adverse Event
2
2
0

Baseline Characteristics

The Realtime Detection for Individual Variation of Analgesic :A Comparison of Sufentanil vs Fentanyl

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Sufentanil Group
n=40 Participants
Grouped by intravenous injection of sufentanil at the time of anesthesia induction
Fentanyl Group
n=40 Participants
Grouped by intravenous injection of fentanyl at the time of anesthesia induction
Saline Group
n=40 Participants
Grouped by intravenous injection of saline before the time of anesthesia induction
Total
n=120 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
0 Participants
n=483 Participants
Age, Categorical
Between 18 and 65 years
40 Participants
n=93 Participants
40 Participants
n=4 Participants
40 Participants
n=27 Participants
120 Participants
n=483 Participants
Age, Categorical
>=65 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
0 Participants
n=483 Participants
Age Continuous
49 years
STANDARD_DEVIATION 12 • n=93 Participants
47 years
STANDARD_DEVIATION 13 • n=4 Participants
49 years
STANDARD_DEVIATION 11 • n=27 Participants
48 years
STANDARD_DEVIATION 13 • n=483 Participants
Sex: Female, Male
Female
40 Participants
n=93 Participants
40 Participants
n=4 Participants
40 Participants
n=27 Participants
120 Participants
n=483 Participants
Sex: Female, Male
Male
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
0 Participants
n=483 Participants
Region of Enrollment
China
40 participants
n=93 Participants
40 participants
n=4 Participants
40 participants
n=27 Participants
120 participants
n=483 Participants

PRIMARY outcome

Timeframe: 10 minutes after the procedure

According to the measurement of pressure pain threshold after intravenous injection of opioid analgesics

Outcome measures

Outcome measures
Measure
Sufentanil Group
n=38 Participants
Grouped by intravenous injection of sufentanil at the time of anesthesia induction
Fentanyl Group
n=38 Participants
Grouped by intravenous injection of fentanyl at the time of anesthesia induction
Saline Group
n=40 Participants
Grouped by intravenous injection of saline before the time of anesthesia induction
Mean Pressure Pain Threshold
9.93 kg/cm2
Standard Deviation 3.50
6.20 kg/cm2
Standard Deviation 3.00
2.36 kg/cm2
Standard Deviation 0.97

PRIMARY outcome

Timeframe: 10 minutes after the procedure

According to the measurement of Nacro-trend index after intravenous injection of opioid analgesics. Narco-trend index is from 0 to 100 which 0 represent deep sedation, and 100 represent waking state.

Outcome measures

Outcome measures
Measure
Sufentanil Group
n=38 Participants
Grouped by intravenous injection of sufentanil at the time of anesthesia induction
Fentanyl Group
n=38 Participants
Grouped by intravenous injection of fentanyl at the time of anesthesia induction
Saline Group
n=40 Participants
Grouped by intravenous injection of saline before the time of anesthesia induction
Mean Value of Narco-trend Index
50.9 units on a scale
Standard Deviation 18.3
70.4 units on a scale
Standard Deviation 27.3
93.7 units on a scale
Standard Deviation 11.8

SECONDARY outcome

Timeframe: 10 minutes after the procedure

According to the measurement of mean arterial pressure before and after intravenous injection of opioid analgesics

Outcome measures

Outcome measures
Measure
Sufentanil Group
n=38 Participants
Grouped by intravenous injection of sufentanil at the time of anesthesia induction
Fentanyl Group
n=38 Participants
Grouped by intravenous injection of fentanyl at the time of anesthesia induction
Saline Group
n=40 Participants
Grouped by intravenous injection of saline before the time of anesthesia induction
Mean Arterial Pressure
90.1 mmHg
Standard Deviation 9.7
89.7 mmHg
Standard Deviation 12.8
90.3 mmHg
Standard Deviation 14.0

SECONDARY outcome

Timeframe: 10 minutes after the procedure

According to the measurement of heart rate before and after intravenous injection of opioid analgesics

Outcome measures

Outcome measures
Measure
Sufentanil Group
n=38 Participants
Grouped by intravenous injection of sufentanil at the time of anesthesia induction
Fentanyl Group
n=38 Participants
Grouped by intravenous injection of fentanyl at the time of anesthesia induction
Saline Group
n=40 Participants
Grouped by intravenous injection of saline before the time of anesthesia induction
Mean Heart Rate
77.9 beats per minute
Standard Deviation 10.1
74.4 beats per minute
Standard Deviation 12.9
77.6 beats per minute
Standard Deviation 13.9

SECONDARY outcome

Timeframe: 10 minutes after the procedure

According to the measurement of respiratory frequency after intravenous injection of opioid analgesics

Outcome measures

Outcome measures
Measure
Sufentanil Group
n=38 Participants
Grouped by intravenous injection of sufentanil at the time of anesthesia induction
Fentanyl Group
n=38 Participants
Grouped by intravenous injection of fentanyl at the time of anesthesia induction
Saline Group
n=40 Participants
Grouped by intravenous injection of saline before the time of anesthesia induction
Mean Respiratory Frequency
13.9 breaths per minute
Standard Deviation 3.3
12.3 breaths per minute
Standard Deviation 2.2
16.1 breaths per minute
Standard Deviation 3.1

Adverse Events

Sufentanil Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Fentanyl Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Saline Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Xianwei Zhang

Huazhong University of Science&Technology

Phone: 027 83662853

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place